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A B S T R A C T   
The HPV vaccine is recommended for all adolescents starting at age 11, but coverage is low, especially in the 
young adult population. The CDC is prioritizing catch-up vaccination and has expanded recommendations for all 
young adults to age 26. College students may be ideal targets for HPV vaccine interventions as they typically 
have on-site clinics that offer prevention services and students are in the position to make decisions about their 
own healthcare. We examined the risk perceptions of 101 HPV vaccine-naïve college students, both in terms of 
risk cognition (beliefs about susceptibility to HPV-related cancers and genital warts) and affect (worry and fear 
regarding HPV-related health outcomes) as they relate to HPV vaccine intentions. Participants completed an 
online survey, reporting absolute and comparative risk perceptions for HPV-related cancers/genital warts, fear 
and worry related to getting HPV-related cancer and/or genital warts, desire for positive emotions, affective 
associations with the HPV vaccine, and intentions to get the HPV vaccine. More fear/worry about vaccination 
was directly associated with increased vaccine intentions. The perceived risk to intentions relation included an 
indirect effect via fear/worry. Desire for positive affect strengthened this relation. Positive affective associations 
with the HPV vaccine were also related to increased vaccine intentions. Given the public health impact of 
increasing HPV vaccine coverage for young adults, educational strategies framing the HPV vaccine positively 
while decreasing fear/worry related to negative health outcomes might increase interest in on-campus catch-up 
vaccination.   
1. Introduction 
In the United States, human papillomavirus (HPV) is the most 
commonly diagnosed sexually transmitted infection (Satterwhite et al., 
2013). The HPV vaccine, which has been recommended for adolescent 
and young adult women since 2006 and adolescent and young adult 
men since 2009 (CDC, 2016), is expected to significantly reduce in-
cidence of HPV, with the overarching goal of reducing morbidities re-
lated to the virus. Since the introduction of the HPV vaccine, population 
coverage has remained low. While Healthy People 2020 goals include 
80% coverage of the two dose nanovalent vaccine for adolescents ages 
13–15 (ODPHP, 2020), only 49% of 13–17 year-olds in the United 
States received all recommended doses in 2017 (CDC, 2018). Data from 
the same survey showed that over 80% of same age adolescents had 
received Tetanus, Diphtheria, Pertussis, and Meningococcal vaccines, 
which are recommended to be given concomitantly with the HPV 
vaccine. While squamous cell cervical cancer rates have slightly de-
creased due to secondary prevention pap screening, rates of HPV-at-
tributable oropharyngeal cancers are on the rise (Mourad et al., 2017). 
Thus, it is important to increase HPV vaccine coverage for both young 
women and men as a key primary prevention tool. 
College students are a key population to prioritize in terms of HPV 
vaccine uptake and coverage. HPV vaccination policies have recently 
shifted to target pre and early-pubertal adolescents prior to age 13 
(Bernstein et al., 2017a, 2017b; Meites et al., 2016). Evidence suggests 
adolescents ages 13 and older are less likely to complete the HPV 
vaccine series. Currently, 23 million young adults ages 19–26 are un-
vaccinated (Williams et al., 2017). In 2016, only 16% of unvaccinated 
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13 to 17-year olds received both doses. Additionally, adolescents were 
less likely to initiate the HPV vaccine as age increased, with only 7% 
initiation after age 15 (Bednarczyk et al., 2019). Such low vaccination 
rates highlight the need for effective catch-up vaccination strategies 
targeting young adult populations outside of the recommended vacci-
nation schedule. In fact, the CDC Advisory Committee on Immunization 
practices recently recommended an expansion of the age range for 
vaccination to 26 years for both men and women, and for clinicians to 
engage in shared decision making with older patients (ages 27–45) who 
might benefit from its use (CDC, 2019). 
Students on a college campus may be ideal targets for HPV vaccine 
decision-making interventions as most American four-year university 
campuses have on-site health services that offer the vaccine at free or 
low cost to students (Barnard et al., 2017), alleviating some of the 
common structural barriers associated with low vaccination rates in 
other contexts (Fisher et al., 2016). Unlike younger adolescent popu-
lations who rely on parents and pediatricians to make vaccination de-
cisions, college students make their own decision about healthcare. In 
addition, college health centers are accustomed to providing prevention 
services and sexual healthcare to emerging adults (Eisenberg et al., 
2012; Coor et al., 2018). As increasing HPV vaccine coverage is a na-
tional priority (ODPHP, 2020), it is important to understand factors that 
impact college students’ HPV vaccine decision making. 
One component of health decision making is a feeling state or 
emotion associated with a specific prevention behavior, or an affective 
association. These affective associations have been shown to directly 
relate to preventive health behaviors, including cancer screening 
(Brown-Kramer and Kiviniemi, 2015; Kiviniemi et al., 2014; Klasko- 
Foster et al., 2018), fruit and vegetable consumption (Kiviniemi and 
Duangdao, 2009), and physical activity (Kiviniemi et al., 2007). In the 
context of prevention behavior, changing the way individuals feel about 
a behavior has been shown to improve a desired health behavior. For 
instance, an experimental study randomly priming participants with 
positive, negative, and neutral affective associations with condom use 
prior to a condom selection task resulted in greater number of condoms 
taken for individuals receiving the positive affect manipulation (Ellis 
et al., 2015). As such, a better understanding of how young adults feel 
about both the HPV vaccine and HPV-related health outcomes may 
inform communication strategies and educational initiatives to increase 
catch-up HPV vaccination for college students. 
1.1. The role of risk perceptions in predicting HPV vaccine behavior 
Risk perceptions, which are comprised of both beliefs about the 
likelihood of acquiring a disease (cognitions) and emotions associated 
with a disease outcome (affect), have been studied in the context of 
HPV in young adult populations, however; they have typically been 
modeled as two distinct main effects (Reiter et al., 2010; Bennett et al., 
2012; Gilbert et al., 2011). Previous research focused on cognitive as-
pects of risk perception in a college student population shows that in-
creased perceived risk of an HPV-related disease outcome was posi-
tively associated with self-efficacy to get vaccinated, which in turn 
influenced vaccine intentions (Christy et al., 2019). Male college stu-
dents who believed they were susceptible to the HPV virus were more 
likely to talk to a provider about getting the HPV vaccine (Katz et al., 
2012) and had greater intentions to get the vaccine (Gerund and Barley, 
2009). By understanding the relative importance and interplay between 
cognitive and affective components of risk in this population, we can 
tailor interventions to maximize HPV vaccine uptake for young adults 
utilizing college campus health services. 
When affective components of perceived risk for HPV-related health 
outcomes have been examined, constructs such as fear and worry have 
been modeled in separate studies from cognitive risk perceptions or as 
two independent main effects. Among young adult men who have sex 
with men, increased worry about getting HPV predicted increased 
vaccine intentions (Cummings et al., 2015). Vaccinated college students 
reported in a qualitative study that getting the HPV vaccine attenuated 
worry about getting an STI in the future (Pitts et al., 2017). Research 
assessing the separate effects of both affective and cognitive risk com-
ponents on HPV vaccine intentions in college students has shown mixed 
results. One experimental study manipulating the level of perceived 
vulnerability (both affective and cognitive) of acquiring HPV-related 
cancer and genital warts through message framing found both affective 
and cognitive components to be separate predictors of HPV vaccine 
intentions in college students, with larger effect sizes for affective 
predictors (Richards, 2016). Other work modeling HPV-related worry 
and perceived susceptibility of the HPV virus separately on HPV vac-
cine intentions among male college students found that worry, but not 
cognitively-based risk perceptions predicted intentions (Grace-Leitch 
and Shneyderman, 2016). Research including main effects of both 
cognitively-based risk perception and anticipated emotions on HPV 
vaccine intentions in male and female college students found that when 
both types of risk components were included in the same model, only 
the emotional component (anticipated regret about not getting vacci-
nated and subsequently acquiring an HPV-related health issue) sig-
nificantly predicted vaccine intentions for men (Christy et al., 2016). 
Although past work has identified both affective and cognitive com-
ponents of risk perceptions as predictors of HPV vaccine intentions, the 
relationship between these variables and the resulting impact on HPV 
vaccine intentions has not been explored. Given the evidence for the 
effects of both affective and cognitively-based risk perceptions in pre-
dicting HPV vaccine intentions, it is important to understand the in-
terplay between these two components. This study provides an initial 
examination of a key theory-driven hypothesis – that while both af-
fective and cognitive components of perceived risk are related to HPV 
vaccine intentions, cognitively-based risk perceptions will indirectly 
influence vaccination intentions through the path of affective compo-
nents of perceived risk (Kiviniemi et al., 2018). 
1.2. The behavioral affective associations model 
The behavioral affective associations model has been used as a 
framework to explain how the interplay between affect and cognitions 
associated with a behavior drive behavioral engagement (Kiviniemi 
et al., 2007). This model of health decision making posits that both 
cognitions and affect are related to decisions to engage in or avoid a 
behavior; however, affective associations mediate the relation between 
cognitions and behavioral practice (Kiviniemi et al., 2007; Kiviniemi 
and Klasko-Foster, 2018). Fig. 1 presents the hypothesized relation 
between variables in the behavioral affective associations model. Past 
work using the behavioral affective associations model has found that 
affective components of risk (worry about getting a disease) tend to be 
more proximal influences on behavioral engagement than cognitive 
components, such as beliefs about personal susceptibility to a disease 
(Kiviniemi and Ellis, 2014; Zhao, 2016; Klasko-Foster et al., 2019). 
Thus, it is important to measure both affective and cognitive 
Fig. 1. The behavioral affective associations model. *Solid lines represent in-
direct effects of affective risk on the relation between cognitive risk and be-
havior, dashed lines represent the absence of a direct effect between cognitive 
risk and behavior when affective risk is added to the model. 
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components of perceived risk in order to account for more variability in 
behavior/intentions. 
1.3. Ideal affect and affective associations with the HPV vaccine 
Ideal affect is a construct that evaluates not how a person actually 
feels, but how someone would ideally like to feel. While people may 
have attitudes about many types of affect, they may only want to feel 
specific affective states (Tsai, 2007). As such, while most people value 
positive affective states over negative, they differ in valuation of arousal 
both individually and cross-culturally. Ideal affect differs from social 
norms in that ideal affect is the way people want to feel, which is not 
always the same as what people think they should feel; however, there 
are cultural differences in valuation of arousal. High arousal positive 
affect (excitement) has been shown to be more desirable among people 
from Western cultures, while low arousal positive affect (serenity) has 
been shown to be more desirable among people from Eastern cultures 
(Tsai, 2007; Tsai et al., 2006; Sims and Tsai, 2015). Differences between 
actual affect and ideal affect motivate behavior that will get an in-
dividual closer to their ideal affective state (Tsai, 2007). Worry and fear 
are both high arousal negative affective states. Given previous work 
showing that disparities between actual and ideal affect can motivate 
behavior (Tsai, 2017), the relation between affectively-based perceived 
risk may be strengthened when individuals have more high arousal 
negative affect associated with genital warts and cancer, the two pri-
mary morbidities of HPV infection, but value low arousal positive af-
fect. As such, we are interested in the extent that a discrepancy between 
actual and ideal affect moderates the relation between perceived risk of 
HPV-related health outcomes and HPV vaccine intentions. 
Finally, we are interested in how affective associations with the HPV 
vaccine itself influences HPV vaccine intentions. Across behavioral 
domains, affect is a strong predictor of behavioral engagement 
(Kiviniemi and Klasko-Foster, 2018). Evidence for the effects of affec-
tive associations on health decision making can be found in recent re-
search on eating behaviors (Kiviniemi and Duangdao, 2009; Walsh and 
Kiviniemi, 2014; Jun and Arendt, 2016), smoking (Lawton et al., 2007), 
physical activity (Kiviniemi et al., 2007; Lawton et al., 2009; Helfer 
et al., 2015), cancer screening (Brown-Kramer and Kiviniemi, 2015; 
Kiviniemi et al., 2014; Klasko-Foster et al., 2019; Zhao and Nan, 2016), 
sunscreen use (Kiviniemi and Ellis, 2014), and donating biospecimens 
for research (Kiviniemi et al., 2013). To our knowledge, the relations 
between positive and negative affective associations with the HPV 
vaccine and behavioral intentions has not been tested 
1.4. Current study 
We are interested in whether affect and cognitions associated with 
risk for two HPV-related disease outcomes (genital warts and cancer), 
are associated with vaccination intentions. Based on the behavioral 
affective associations model, we hypothesize that both cognitive and 
affective components of perceived risk for genital warts and HPV-re-
lated cancer will have significant effects on future HPV intentions 
(hypothesis 1). According to the behavioral affective associations 
model, affective components will mediate the relation between cogni-
tive components and future vaccine intentions and affective compo-
nents will be associated with HPV vaccine behavior even after ac-
counting for the influence of cognitive components (hypothesis 2). 
When ideal affect is added to this model, (Fig. 2) we hypothesize that 
high arousal positive ideal affect will increase the strength of the re-
lation between affective components of perceived risk and intentions to 
get the HPV vaccine (hypothesis 3). Finally, we hypothesize that 
stronger positive affective associations and weaker negative affective 
associations with the HPV vaccine itself will encourage individuals to 
engage in HPV vaccination behavior (hypothesis 4). 
2. Materials and methods 
2.1. Participants and procedures 
Participants, ages 18–26, were recruited from a college campus via 
posted flyers in common areas of buildings and emailed flyers sent 
through student interest groups (e.g. the Asian American Student 
Union) with a link inviting interested participants to complete an online 
questionnaire. Recruitment occurred in two waves; the first wave of 
recruitment occurred during fall semester 2017 and the second wave 
occurred during fall semester 2018. Eligibility criteria included young 
adults age-eligible for the HPV vaccine who had not been exposed to 
the HPV vaccine prior to study enrollment and felt comfortable reading 
and answering survey questions in English. Individuals who screened 
eligible were consented to participate online. Participants who com-
pleted the cross-sectional survey (average time to completion was 
45 min) were offered $10 in credits added to their university identifi-
cation cards (wave 1) or $10 electronic Amazon gift cards (wave 2). To 
estimate the necessary sample size, we followed Fritz and Mackinnon’s 
guidelines to detect a small to moderate effect (b’s between 0.14 and 
0.25) for both indirect paths in a mediation model utilizing bias-cor-
rected bootstrapping (Fritz and MacKinnon, 2007). The study protocol 
was approved by the Institutional Review Board at xxxx (omitted for 
blind review). 
2.2. Measures 
2.2.1. HPV knowledge and awareness 
Items were selected from previous studies (Reiter et al., 2010; Licht 
et al., 2010). To gauge awareness, participants were asked, “Have you 
heard of the HPV vaccine before today?” with response options: yes, no, 
and don’t know. Fourteen questions were asked to measure knowledge, 
each with response options: yes, no, don’t know. A total knowledge 
score was computed by summing all correct answers (range 0–14). 
Participants were asked questions regarding whether HPV causes pro-
blems for women and men, modes of transmission, HPV-related nega-
tive health outcomes, HPV prevalence, risk behaviors. 
2.2.2. Cognitively-based perceived risk 
Participants responded to items assessing absolute risk and com-
parative risk for multiple HPV-related morbidities, including genital 
warts, cervical cancer, anal cancer, and oral cancer; adapted from 
previous work (Reiter et al., 2009; Moser et al., 2007). For each mor-
bidity, participants who had no previous exposure to the HPV vaccine 
were asked the following to measure absolute risk, “What is the chance 
that you will ever get____?” on a 5-point Likert scale, with endpoints of 
1 = no chance and 5 = high chance. Comparative risk was assessed 
with the following question: “Compared to others of your age and 
gender, how likely are you to get ____?” with response options of less 
likely, equally likely, and more likely. 
Fig. 2. A conceptual model, including ideal affect.  
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2.2.3. Affectively-based perceived risk 
Participants responded to single items assessing worry and fear 
about a) cancer and b) genital warts: “How worried are you about 
getting ____?” and “How afraid are you of getting ____?” (Moser et al., 
2007). Response options were on a 5-point scale with endpoints 
1 = not at all and 5 = extremely. 
2.2.4. Ideal affect 
Ideal affect was measured using 25 items adapted from Tsai and 
Knutson (2005). For this analysis, only the 6 items that measured high 
arousal and low arousal positive affect were included. For each type of 
affective state, participants were asked to report how often he/she 
would ideally like to feel that affective state on a 5-point Likert scale 
with endpoints 1 = not at all and 5 = all of the time. High arousal 
positive ideal affect included three affective states (enthusiastic, ex-
cited, elated) and low arousal positive ideal affect included three af-
fective states (calm, relaxed, serene). Mean measures for each subscale 
were computed for analysis. Reliability for the high arousal positive 
ideal affect was α = 0.72 and low arousal positive ideal affect was 
α = 0.66, which is consistent with other literature measuring ideal 
affect (Tsai et al., 2006). 
2.2.5. Affective associations with the HPV vaccine 
Affective associations were assessed by asking respondents to think 
about the HPV vaccine and then report agreement with four positive 
affective states (e.g. “Do you feel relaxed?), and five negative affective 
states (“Do you feel sad?”) on a 5-point scale with endpoints 1 = not at 
all and 5 = extremely using a modified measure of affective attitude 
components (Crites et al., 1994). Modifications were made to separate 
positive and negative affective states and mean scores were created 
(Kiviniemi, 2018). Reliability for the positive and negative affective 
association scales were α = 0.94 and α = 0.92, respectively. Both 
individual items and aggregate scales were used in analyses. 
2.2.6. Outcome measures 
Key outcomes for this study were HPV vaccination intentions 
(Reiter et al., 2010; Gerend et al., 2008). Past vaccine behavior was 
measured by asking how many shots of the HPV vaccine each partici-
pant had received. “Don’t know” responses were not included in this 
analysis. Intentions were analyzed for HPV vaccine naïve individuals 
only (participants reported 0 shots received). Participants were asked 
on a 5-point Likert scale how likely they were to get the HPV vaccine in 
the next twelve months. Responses were on a 5-point Likert scale with 
endpoints of 1 = not at all likely to 5 = extremely likely. 
2.3. Analysis plan 
All analyses were conducted using SPSS 24. Descriptive analyses, 
including percentages, means and standard deviations, were performed 
on the demographic characteristics of the participants (age, gender, 
race, country of origin) and on the outcome and predictor variables. 
Linear regression was used to test models of each component of risk 
separately on HPV vaccine intentions. We estimated mediation models 
using bootstrap estimation via the SPSS PROCESS macro (Hayes, 2012). 
Next, ideal affect was added to the mediation models to assess any 
interaction with affective risk perceptions. We tested associations be-
tween individual and the aggregate positive and negative affective as-
sociations with the HPV vaccine and HPV vaccination intentions using 
linear regression. Parallel models were assessed and compared, both 
including and excluding age, gender, and race. There were no differ-
ences in significance, magnitude and direction of effects between 
models. As such, results reported below are the most parsimonious 
models and do not include demographic controls. As male HPV vaccine 
completion rates lag behind those for women, we used analysis of 
variance to determine differences in each risk perception variable by 
sex. No significant differences were present (Table 1). 
3. Results 
3.1. Participant characteristics 
Of the 423 individuals who clicked on the electronic survey link, 
288 completed the questionnaire. Observations were excluded from this 
analysis if they had already been exposed to the HPV vaccine or re-
ported “don’t know” for past vaccination behavior (n = 174), if they 
did not pass three of the seven attention control tests throughout the 
survey (n = 5), or if they were not current University students (n = 8). 
Demographic characteristics of participants are shown in Table 2. Study 
participants ranged in age from 18 to 26 (mean age = 21). Almost two 
thirds of the sample identified as female, 45% self-reported white race, 
and 26% were international students. 
While 85% of participants were aware of HPV and 78% were aware 
that an HPV vaccine was available to them, neither type of awareness 
measure was associated with behavioral intentions to get the vaccine. 
Similarly, HPV knowledge was not associated with vaccine intentions. 
Mean scores on the 14-point knowledge measure were 6.5 (SD = 3.8). 
3.2. Do both cognitive and affective risk perceptions influence HPV vaccine 
intentions? 
The direct effects of each cognitive (absolute and comparative risk) 
and affective (worry and fear) risk variable for both genital warts and 
Table 1 
Mean risk perceptions and significant differences by gender (n = 101).       
Construct Men  
(n = 39) 
Women  
(n = 62) 
F-Ratio p-value 
Mean (SD) Mean (SD)  
Absolute risk: genital warts 2.23 (0.68) 2.10 (0.81)  0.60  0.44 
Absolute risk: HPV-related 
cancer 
2.14 (0.64) 2.13 (0.81)  0.004  0.95 
Comparative risk: genital 
warts 
1.35 (0.63) 1.36 (0.64)  0.004  0.95 
Comparative risk: HPV- 
related cancer 
1.48 (0.72) 1.35 (0.65)  0.61  0.44 
Worry: genital warts 2.16 (0.95) 2.18 (1.28)  0.01  0.92 
Worry: HPV-related cancer 2.21 (1.02) 2.37 (1.23)  0.45  0.51 
Fear: genital warts 2.11 (0.86) 2.37 (1.26)  1.26  0.27 
Fear: HPV-related cancer 2.32 (0.99) 2.51 (1.42)  0.53  0.47 
Table 2 
Participant Characteristics (n = 101).       
N M (SD) or 
%  
Age  101 21.0 (2.2)  
Sex Male 39 38.6 
Female 62 61.4  
Race White 45 44.6 
Asian 39 38.6 
Black/African American 10 9.9 
American Indian /Alaska 
Native 
1 1.0 
Other 6 5.9  
Type of student International 26 25.7 
Domestic 75 74.3  
Highest education level 
completed 
High school 5 5.0 
College 1st year 12 11.9 
College 2nd year 25 24.8 
College 3rd year 26 25.7 
College 4th year 16 15.8 
Graduate school 1st year 10 9.9 
Graduate school 2nd year 5 5.0 
Graduate school 4th year 2 1.9 
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HPV-related cancer were estimated using separate linear regression 
models (Table 3). Greater absolute and comparative risk for genital 
warts was associated with greater vaccine intentions. Greater fear and 
worry about getting genital warts was also positively associated with 
HPV vaccine intentions. For HPV-related cancer risk perceptions, 
greater absolute risk, cancer worry, and cancer fear were associated 
with greater vaccine intentions. Comparative risk for HPV-related 
cancer was not significantly associated with HPV vaccine intentions. 
3.3. Do affective components of perceived risk mediate the relation between 
cognitive components and intentions? 
We took a three-step approach to determine whether the effects of 
cognitively-based risk perceptions were indirectly associated with HPV 
vaccine intentions through the path of affective components of per-
ceived risk. First, we estimated regression models with cognitive risk 
variables predicting each affective risk component independently. We 
found significant, positive associations for each relation (Table 4). Next, 
we used bootstrap estimation to model the indirect effects of each af-
fective risk component as independent mediators of the relation be-
tween cognitively-based perceived risk and HPV vaccine intentions. 
Results of mediation analyses are shown in Table 5. The association 
between absolute risk of genital warts and HPV vaccine intentions was 
partially mediated by fear, but not worry. Affective components of risk 
(fear/worry) did not mediate the relation between absolute risk of HPV- 
related cancer and HPV vaccine intentions. The association between 
comparative risk of genital warts and vaccine intentions was fully 
mediated by both worry and fear. The relation between comparative 
risk of HPV-related cancer and HPV vaccine intentions was fully 
mediated by worry, but not fear. Last, we examined the independent 
influences of affective components on each significant mediation 
model. The residual score representing the portion of variance of each 
affective variable not related to cognitive risk in each model was cal-
culated. HPV vaccine intentions were regressed on each residual score. 
The residual slopes were significant for fear of genital warts in both 
cognitive risk models (absolute risk: b = 0.25, p  <  0.05; comparative 
risk: b = 0.37, p  <  0.01). Residual slopes were also significant for all 
mediation models including comparative risk and worry (comparative 
risk for genital warts: b = 0.34, p  <  0.01; comparative risk for HPV- 
related cancer: b = 0.24, p  <  0.05). These significant relations 
indicate an independent effect of affectively-based perceived risk on 
vaccine intentions. 
3.4. Does positive ideal affect strengthen the relation between affectively- 
based risk perceptions and HPV vaccine intentions? 
We completed the moderated mediation analysis using the 
PROCESS macro to obtain bootstrapped confidence intervals for the 
aforementioned mediation models at different levels of positive ideal 
affect. Moderation was assessed on the path between the mediator and 
outcome variable. It was expected that people who valued high arousal 
positive emotions, such as excitement, relatively more than others 
would have stronger associations between affective components of 
perceived risk and HPV vaccine intentions. Moderated mediation was 
present in models in which both fear and worry about genital warts 
mediated the relation between cognitive risk components and HPV 
vaccine intentions. For all models, interactions were assessed by testing 
the conditional indirect effects of affective risk at three levels of either 
high arousal or low arousal positive ideal affect: the mean, one standard 
deviation above the mean, and one standard deviation below the mean. 
Both high and low arousal positive ideal affect significantly mod-
erated the relation between perceived risk and HPV vaccine intentions 
such that when individuals had moderate to high positive ideal affect, 
the relation between affective components of risk and HPV vaccine 
intentions was stronger compared to those with lower positive ideal 
affect. In all models with significant indices of moderated mediation, 
indirect effects of affectively-based risk perceptions were strongest and 
significant at higher levels of positive ideal affect. When the relation 
between absolute risk for genital warts and HPV vaccine intentions was 
mediated by worry, the index of moderated mediation was significant 
for high arousal positive ideal affect (index = 0.12; 95% CI, 0.01–0.30; 
R2 = 0.26). The indirect effects of worry were significant for partici-
pants with moderate (b = 0.11; 95% CI, 0.02 to 0.27) and high 
(b = 0.21; 95% CI, 0.05–0.44), but not low (b = 0.01; 95% CI, −0.13 
to 0.14) levels of high arousal ideal affect. The index of moderated 
mediation was also significant for low arousal positive ideal affect 
(index = 0.12; 95% CI, 0.02–0.29; R2 = 0.23). The indirect effects of 
worry were significant for participants with moderate (b = 0.13; 95% 
CI, 0.02–0.34) and high (b = 0.22; 95% CI, 0.05–0.50), but not low 
(b = 0.04; 95% CI, −0.06 to 0.22) levels of low arousal ideal affect. 
When fear was modeled as a mediator in the relation between ab-
solute risk for genital warts and HPV vaccine intentions, patterns were 
similar for both high arousal ideal affect (index = 0.09; 95% CI, 
0.004–0.30; R2 = 0.28) and low arousal ideal affect (index = 0.10; 
Table 3 
Direct effects of perceived risk variables on intentions to get the HPV Vaccine in 
the next 12 months, classified by health outcome (n = 101).     
Risk variable Genital warts HPV-related cancer*  
Absolute risk b = 0.39, p  <  0.001 b = 0.26, p  <  0.05 
Comparative risk b = 0.25, p  <  0.05 b = 0.15, p = 0.21 
Worry b = 0.42, p  <  0.001 b = 0.29, p  <  0.01 
Fear b = 0.43, p  <  0.001 b = 0.23, p  <  0.05 
*HPV-related cancer includes questions about HPV-related anal, oral, and cer-
vical cancers. For male respondents, only HPV-related anal and oral cancer 
questions were presented.  
Table 4 
Univariable relations between cognitively-based risk perceptions and affec-
tively-based risk perceptions (n = 101).     
Risk variable Worry Fear  
Absolute risk: genital warts b = 0.38, p  <  0.01 b = 0.30, p  <  0.01 
Absolute risk: HPV-related 
cancer 
b = 0.55,  
p  <  0.001 
b = 0.39, p  <  0.001 
Comparative risk: genital 
warts 
b = 0.35, p  <  0.01 b = 0.28, p  <  0.05 
Comparative risk: HPV-related 
cancer 
b = 0.39, p  <  0.01 b = 0.27, p  <  0.05 
Table 5 
Affectively-based Perceived Risk as a Mediator of the Relation between 
Cognitively-based Risk Perceptions and HPV Vaccine Intentions in the Next 12 
Months (n = 101).       
Cognitive Risk Affectively-based Perceived Risk 
Worry (cancer or genital 
warts) 
Fear (Cancer or genital warts) 
Direct Indirect Direct Indirect  
Absolute risk 
genital warts 
0.40 
(0.12, 0.69) 
0.09 
(−0.01, 
0.27) 
0.40 
(0.13, 
0.27) 
0.10 
(0.01, 0.30) 
Absolute risk cancer 0.24 
(−0.10, 
0.58) 
0.14 
(−0.05, 
0.35) 
0.32 
(0.01, 
0.63) 
0.01 
(−0.03, 0.24) 
Comparative risk 
warts 
0.20 
(−0.18, 
0.58) 
0.20 
(0.05, 0.43) 
0.23 
(−0.13, 
0.59) 
0.17 
(0.04, 0.39) 
Comparative risk 
cancer 
0.07 
(−0.28, 
0.44) 
0.15 
(0.01, 0.40) 
0.15 
(−0.20, 
0.50) 
0.07 
(−0.002, 
0.23) 
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95% CI, 0.01–0.29; R2 = 0.26). The indirect effects of fear were sig-
nificant for participants with moderate (b = 0.12; 95% CI, 0.03–0.28) 
and high (b = 0.20; 95% CI, 0.03–0.43), but not low (b = 0.05; 95% 
CI, −0.07 to 0.18) levels of high arousal ideal affect. The indirect ef-
fects of fear were significant for participants with moderate (b = 0.12; 
95% CI, 0.03–0.28) and high (b = 0.19; 95% CI, 0.04–0.41), but not 
low (b = 0.04; 95% CI, −0.07 to 0.18) levels of low arousal ideal 
affect. Neither high nor low arousal positive ideal affect changed the 
relations between any of the variables in models estimating compara-
tive risk for genital warts and absolute and comparative risk for HPV- 
related cancers. 
3.5. Do affective associations with the HPV vaccine itself predict vaccine 
intentions? 
We used linear regression to estimate associations between ag-
gregate responses for positive and negative affective associations, and 
individual affective associations as predictors of HPV vaccine inten-
tions. Positive affective associations were associated with increased 
HPV vaccine intentions (b = 0.33, p  <  0.01). In addition, each of the 
positive individual affective associations with the HPV vaccine were 
significantly related to greater vaccine intentions (happy: b = 0.29, 
p  <  0.01; delighted: b = 0.35, p  <  0.01; satisfied: b = 0.30, 
p  <  0.01; relaxed: b = 0.36, p  <  0.001). Neither aggregate 
(b = −0.03, p = 0.78) nor individual negative affective associations 
(disgusted: 0.02, p = 0.83; angry: b = −0.01, p = 0.96; annoyed: 
b = 0.004, p = 0.97; sad: b = 0.04, p = 0.71; afraid: b = 0.02, 
p = 0.85) were significantly related to HPV vaccine intentions. 
4. Discussion 
Although awareness of the HPV vaccine was high in this population, 
accurate knowledge about HPV was low. On average, participants 
correctly answered fewer than half of the HPV knowledge questions. 
This is consistent with other work assessing HPV knowledge/vaccine 
awareness among college students (Albright and Allen, 2018; Cooper 
et al., 2018; Fisher et al., 2014; Thompson et al., 2016). As such edu-
cational intervention may be necessary to persuade unvaccinated stu-
dents of the worthiness of this preventive health behavior, especially as 
accurate HPV knowledge is related to increased intentions for college 
students to obtain the vaccine in other work (Cooper et al., 2018). 
Affect, whether it is associated with risk perceptions about a disease 
state or with a vaccine, or valued as an ideal state, is important to 
understanding HPV vaccine intentions in a college student population. 
Worry and fear were associated with HPV vaccine intentions and both 
worry and fear mediated relations between cognitively-based perceived 
risk and behavioral intentions. Furthermore, worry and fear were re-
lated to HPV vaccine intentions over and above cognitions about risk, as 
established through an independent pathway analysis. These findings 
are consistent with the behavioral affective associations model and 
indicate that affective components of risk may play a central role in 
primary prevention decision making. 
4.1. Implications 
The mediated relation between cognitive and affectively-based risk 
perceptions as influencers of HPV vaccine intentions has implications 
for understanding how risk informs decision making for primary pre-
vention behaviors. This work underscores that the measurement of risk 
perceptions should include assessments of both affective and cognitive 
components. By only assessing cognitive components, we are unable to 
assess the possible connection between risk perceptions and worry/fear 
about HPV-related health outcomes, which may drive behavioral in-
tentions. Relatedly, interventions that only work to change cognitive 
risk perceptions may exclude affective risk perceptions that are critical 
to decision making and thus, the effectiveness of the intervention. 
Evidence exists for the effect of anticipatory emotions in vaccination 
decision making (Christy et al., 2016; Chapman and Coups, 2006; 
Weinstein et al., 2007). In this study, both valuing high and low arousal 
positive affect moderated the mediated relation between risk compo-
nents and intentions, by strengthening the association between affec-
tive components of perceived risk and HPV vaccine intentions. Our 
findings show that cognitive and affectively-based perceived risk for 
both genital warts and HPV-related cancers had significant main effects 
and indirect effects on HPV intentions, but ideal affect only moderated 
the relation for fear and worry about genital warts, not HPV-related 
cancers. It could be the case that genital warts are associated with more 
negative affect than cancer; thus, more positive ideal affect is associated 
with a more immediate response. Finding that any positive ideal affect 
increases the strength of the relation between worry/fear and vaccine 
intentions paired with the knowledge that positive affective associa-
tions with the vaccine are behavior motivating has implications for 
health communication interventions. As worry/fear increases the like-
lihood that someone may get the vaccine, and that effect is intensified 
by wanting to feel more positive affect of any type, communication 
strategies could highlight the positive affect experienced after getting 
the vaccine, such as feeling peace of mind with the knowledge that the 
vaccine prevents lifetime risk of genital warts and HPV-related cancers. 
This work shows that college students do have increased risk per-
ceptions about HPV that are predictive of behavioral intentions. These 
findings may be useful as part of a health communication strategy on 
college campuses. Student health centers could be an ideal setting for 
vaccine naïve young adults to obtain preventive vaccinations; specifi-
cally, many students utilize these resources for primary care (Turner 
and Keller, 2015), and over 12 million young adults under age 25 are 
enrolled in American colleges and universities (NCES, 2018); however; 
campus health centers may not be providing easily accessible in-
formation about HPV vaccine education or availability. A recent ana-
lysis of college health center websites at 214 American universities 
found that only 50% mentioned HPV vaccine and only 32% of those 
provided any additional information such as costs and availability 
(Fontenot et al., 2016). Research regarding health communication ap-
proaches to increase HPV vaccine suggests a preference for strong, 
straight-forward recommendations (Malo et al., 2016). University 
health centers should work to include brief, direct information on their 
websites about the benefits of HPV vaccine, with particular attention to 
positive emotions and reduction of worry and fear. Additionally, stu-
dent health services may consider the importance of increased avail-
ability of information using mass media and social media campaigns in 
general terms (e.g., sexual health programs) as well as specific services 
(e.g., catch-up vaccinations). Providers at student health centers can 
help increase student knowledge about HPV, which may help increase 
risk perceptions. 
4.2. Limitations 
Some limitations should be considered regarding this work. First, 
results are cross-sectional and limit our ability to make causal state-
ments about relationships between risk components and subsequent 
impact on HPV vaccine intentions. This work adds to existing evidence 
that the behavioral affective associations model may accurately predict 
that cognitive risk perceptions elicit fear and worry and the latter 
motivate protective action; however, future longitudinal work is ne-
cessary to further understand whether worry and fear are causal me-
chanisms. Second, a convenience sample was used in this study. As 
such, this sample may not be representative of the general population of 
college students. 
5. Conclusion 
Current college students are a priority population for HPV vaccine 
intervention as they are age-eligible, likely to be unvaccinated or under- 
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vaccinated, and have the ability to get vaccinated at no or low cost. Our 
work demonstrates that affective components of perceived risk guide 
HPV vaccine decision making. First, worry and fear about HPV-related 
health outcomes mediated the relation between cognitive risk assess-
ment and HPV vaccine intentions. Second, positive ideal affect 
strengthened the relation between affective components of risk and 
HPV vaccine intentions. Third, affective associations with the HPV 
vaccine influenced behavioral intentions when they were positive, and 
not negative. As such, HPV related communications should focus on 
positive emotions associated with both the vaccine and the how the 
resulting protection from vaccination can attenuate worry and fear 
about deleterious HPV-related outcomes. 
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